Impact of Silver Nanoparticles on Haemolysis, Platelet Function and Coagulation
Author(s) -
Julie Laloy,
Valentine Minet,
Lütfiye Alpan,
François Mullier,
Sonja Beken,
Olivier Toussaint,
Stéphane Lucas,
JeanMichel Dogné
Publication year - 2014
Publication title -
nanobiomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.561
H-Index - 12
ISSN - 1849-5435
DOI - 10.5772/59346
Subject(s) - haemolysis , platelet , coagulation , hemolysis , platelet adhesion , adhesion , chemistry , coagulation cascade , platelet adhesiveness , whole blood , nanoparticle , platelet aggregation , coagulation system , thrombin , biophysics , nanotechnology , materials science , immunology , medicine , biology , organic chemistry
Silver nanoparticles (Ag NPs) are increasingly used in biomedical applications because of their large antimicrobial spectrum. Data in the literature on the ability of Ag NPs to perform their desired function without eliciting undesirable effects on blood elements are very limited and contradictory. We studied the impact of Ag NPs on erythrocyte integrity, platelet function and blood coagulation. Erythrocyte integrity was assessed by spectrophotometric measurement of haemoglobin release. Platelet adhesion and aggregation was determined by light transmission aggregometry and scanning electron microscopy. The calibrated thrombin generation test was used to study the impact on coagulation cascade. We demonstrated that Ag NPs induced haemolysis. They also increase platelet adhesion without having any impact on platelet aggregation. Finally, they also had procoagulant potential. Bringing all data from these tests together, the no observed effect concentration is 5 μg/mL.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom